Chloropicrin Manufacturers Task Force
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 854,324 | 944,910 | −90,586 | 0.7 | 0% |
| 2013 | 1,025,164 | 927,487 | 97,677 | 2.0 | 0% |
| 2014 | 1,357,747 | 1,375,298 | −17,551 | 1.2 | 0% |
| 2015 | 1,742,306 | 1,167,540 | 574,766 | 7.3 | 0% |
| 2016 | 1,104,090 | 1,384,867 | −280,777 | 3.7 | 0% |
| 2017 | 1,478,084 | 1,520,188 | −42,104 | 3.0 | 0% |
| 2018 | 1,320,130 | 1,251,853 | 68,277 | 4.4 | 0% |
| 2019 | 828,728 | 1,068,768 | −240,040 | 2.4 | 0% |
| 2020 | 664,486 | 782,479 | −117,993 | 1.5 | 0% |
| 2021 | 826,203 | 742,963 | 83,240 | 2.9 | 0% |
| 2022 | 699,702 | 724,899 | −25,197 | 2.6 | 0% |
| 2023 | 554,728 | 651,840 | −97,112 | 1.1 | 0% |
In its most recent public year (2023), this organization spent $97,112 more than it brought in. Its reserves stood at about 1.1 months of spending. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Chloropicrin Manufacturers Task Force's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works